X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Current Drug Delivery

期刊標題檢索 CURR DRUG DELIV 最新評論: When did you become so different? (2024-05-07)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Current Drug Delivery]您好,您是該頁面的第 27373 位訪客。

期刊簡介
期刊名稱Current Drug Delivery Current Drug Delivery
LetPub Score
5.4
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
9.2

期刊簡稱CURR DRUG DELIV
ISSN1567-2018
E-ISSN1875-5704
h-index54
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.100.4510.481
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q269 / 183

自引率 (2023-2024)7.10%自引率趨勢
掲載範囲
Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.

The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance.

The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.
官方網站http://benthamscience.com/journal/index.php?journalID=cdd
在線稿件提交http://bsp-cms.eurekaselect.com/index.php/CDD/login?source=%2Findex.php%2FCDD
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域PHARMACOLOGY & PHARMACY
出版國/地區U ARAB EMIRATES
發行頻率
創刊年0
每年文章數139每年文章數趨勢
黃金OA百分比0.57%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2158/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-2018%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Current Drug Delivery】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640969
    BIOMATERIALS575682
    BIOMEDICINE & PHARMACOTHERAPY498369
    Frontiers in Pharmacology487375
    JOURNAL OF ETHNOPHARMACOLOGY479457
    Journal of Materials Chemistry B476067
    Frontiers in Immunology458034
    COLLOIDS AND SURFACES B-BIOINTERFACES419249
    COMPUTERS IN BIOLOGY AND MEDICINE416608
    Frontiers in Oncology413512
  •  

    Current Drug Delivery Current Drug Delivery
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Current Drug Delivery] 的評論撰寫評論
作者: 等等等等等邓呐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-07 11:28:50 評論於
When did you become so different?
(0) 讚! | 等等等等等邓呐

作者: 努力啊大慕玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-26 16:31:22 評論於
Review speed: 2.0 | Submission success rate: 50.0
Feedback: The editors are nice and the external review is quite fast. I received feedback in one month. Hope everything goes smoothly
(0) 讚! | 努力啊大慕玉

作者: 万花飞槐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 23:20:00 評論於
very slow
(0) 讚! | 万花飞槐

作者: 无妄雅柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-27 08:55:05 評論於
Is this magazine quick to publish after accepting submissions?
(0) 讚! | 无妄雅柔

作者: 努力啊大慕玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 08:01:49 評論於
Review Speed: 1.0 | Submission Hit Rate: 50.0
Emphasized Research Direction: Drug Delivery Systems
Experience Sharing: It has been almost half a month and still awaiting editor approval
(0) 讚! | 努力啊大慕玉

作者: 问儿酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-08 22:55:51 評論於
Could you tell me how long the approximate turnaround time is for submitting an article to Current Drug Delivery? I have been in the "awaiting for initial checking" status for a long time and it feels very slow
(0) 讚! | 问儿酱吖

作者: Alva Penn


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-06 18:04:59 評論於
Do you need a layout fee of $490?
(0) 讚! | Alva Penn

作者: 北海秀慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-29 09:45:14 評論於
Please translate the following paragraph into English and Japanese
(0) 讚! | 北海秀慧

作者: 孤云崇学


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 23:04:18 評論於
Hello, may I help you?
(0) 讚! | 孤云崇学

作者: 孤云崇学


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-11 12:05:52 評論於
Hello, may I help you?
(0) 讚! | 孤云崇学

作者: 雨巷少年嘉歆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-09 21:08:10 評論於
Does it take half a month from submission to Awaiting For Initial Checking? Is it particularly slow?
(0) 讚! | 雨巷少年嘉歆

作者: 雨巷少年嘉歆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-08 08:58:30 評論於
Is this magazine very slow? It has been half a month and it just started awaiting for initial checking. Is there any hope?
(0) 讚! | 雨巷少年嘉歆

作者: 一只己未呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-11 19:32:00 評論於
May I ask for the English and s of the following paragraph?
(0) 讚! | 一只己未呀

作者: 岭南和玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-03 10:02:29 評論於
Hello, are you online now? My article has been pre-accepted for over two months. Yesterday I received a request for image quality optimization and I paid over 100 dollars. How long will it take for my article to be online?
(0) 讚! | 岭南和玉

作者: 北海秀慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-31 17:29:17 評論於
Do you need a $490 processing fee for the article?
(0) 讚! | 北海秀慧

作者: 北海秀慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-31 08:06:29 評論於
It seems like we might need to consider choosing an OA (online application) as well
(0) 讚! | 北海秀慧

作者: 岭南和玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-21 16:33:45 評論於
Review Speed: 2.0 Experience Sharing: Submitted in early March, received major revisions in early May, accepted one week after revisions, but now it's almost the end of July... and still no proof... Difficulty is not high, those with more time on their hands can give it a try. Also, the impact factor has increased a lot this year, from 2.5 to 3.8
(0) 讚! | 岭南和玉

作者: 岭南和玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-09 08:39:29 評論於
If you don't choose OA, you won't need it anymore
(0) 讚! | 岭南和玉

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:23:35 評論於
The corresponding author of a SCI journal article does not necessarily have to be only one person, there is no fixed standard for the specific number of authors. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if the paper has multiple corresponding authors, the first corresponding author will automatically be selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements. In other words, the number of authors listed as corresponding authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiments and writing of the article, and is the person who is listed first in the author list. However, in collaborative work, it is common to have multiple co-first authors. There is no specific rule regarding the number of co-first authors, and it depends largely on the workload of the paper, its length, the regulations of the publishing journal, and the recognition of the institution. Generally, it is most common for a SCI paper to have 2-4 co-first authors
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:28:25 評論於
Less commonly, it is usually the full Chinese name spelled out
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 21:43:48 評論於
How many corresponding authors can there be at most? How many first authors can there be at most?
(0) 讚! | 深渊兴业

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 10:00:50 評論於
Can the author write their name in Chinese?
(0) 讚! | 北国博达

作者: 断刀凝思


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-29 19:57:13 評論於
I have the same question! It's a research article, and when I submitted it, they asked for article processing charges. But in the submission guidelines, it mentions publication charges as well. I'm confused! Do they want to charge me for both? If they charge for one, my supervisor has already asked me to withdraw the submission!
(0) 讚! | 断刀凝思

作者: 雨巷少年得魁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-10 21:52:17 評論於
What kind of original data needs to be provided?
(0) 讚! | 雨巷少年得魁

作者: 雨巷少年得魁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-10 15:52:11 評論於
How much is the layout fee?
(0) 讚! | 雨巷少年得魁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Current Drug Delivery] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*